165 related articles for article (PubMed ID: 35918108)
1. Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment.
Thomas C; Raibouaa A; Wollenberg A; Capron JP; Krucien N; Karn H; Tervonen T
BMJ Open; 2022 Aug; 12(8):e058799. PubMed ID: 35918108
[TBL] [Abstract][Full Text] [Related]
2. Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment.
Boeri M; Sutphin J; Hauber B; Cappelleri JC; Romero W; Di Bonaventura M
J Dermatolog Treat; 2022 May; 33(3):1449-1458. PubMed ID: 33023361
[TBL] [Abstract][Full Text] [Related]
3. Patient preferences for atopic dermatitis treatments: a discrete choice experiment.
Kwatra SG; Lio P; Weidinger S; Calimlim B; Ladizinski B; Vigna N; Botha W; Mansfield C
J Dermatolog Treat; 2023 Dec; 34(1):2222201. PubMed ID: 37349865
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment.
Feldman SR; Guerin A; Gauthier-Loiselle M; Claxton AJ; Hazra NC; Meng Y; Gallant K; Balu S
J Dermatolog Treat; 2024 Dec; 35(1):2345739. PubMed ID: 38705585
[No Abstract] [Full Text] [Related]
5. Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.
Thomas C; Ailawadhi S; Popat R; Kleinman D; Ross MM; Gorsh B; Mulnick S; O'Neill A; Paka P; Hanna M; Krucien N; Molinari A; Gelhorn HL; Perera S
Front Med (Lausanne); 2023; 10():1271657. PubMed ID: 38076274
[TBL] [Abstract][Full Text] [Related]
6. Patient Preferences in the Treatment of Moderate-to-severe Atopic Dermatitis.
Ameen M; Alhusayen R; Brandi H; Bøgelund M; Jensen HH; Reitzel SB; Thyssen JP
Acta Derm Venereol; 2024 Feb; 104():adv24339. PubMed ID: 38380974
[TBL] [Abstract][Full Text] [Related]
7. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
[TBL] [Abstract][Full Text] [Related]
8. Treatment preferences among patients with mild-to-moderate atopic dermatitis.
Myers K; Silverberg JI; Parasuraman S; Pierce A; Eichenfield LF; Poulos C
J Dermatolog Treat; 2023 Dec; 34(1):2215356. PubMed ID: 37259544
[No Abstract] [Full Text] [Related]
9. Patients' preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most.
Schaarschmidt ML; Kromer D; Wellmann P; Peitsch WK; Kromer C
J Dermatolog Treat; 2024 Dec; 35(1):2308682. PubMed ID: 38297480
[TBL] [Abstract][Full Text] [Related]
10. Patient and physician preferences for atopic dermatitis injection treatments in Japan.
Okubo Y; Ho KA; Fifer S; Fujita H; Oki Y; Taguchi Y
J Dermatolog Treat; 2020 Dec; 31(8):821-830. PubMed ID: 31250681
[No Abstract] [Full Text] [Related]
11. Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment.
Carrascosa Carrillo JM; Baselga Torres E; Gilaberte Calzada Y; Jurgens Martínez YN; Roustan Gullón G; Yanguas Bayona JI; Gómez Castro S; Ferrario MG; Rebollo Laserna FJ
Dermatol Ther (Heidelb); 2022 May; 12(5):1197-1210. PubMed ID: 35445962
[TBL] [Abstract][Full Text] [Related]
12. PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.
Poulos C; Kinter E; van Beek J; Christensen K; Posner J
Int J Technol Assess Health Care; 2018 Jan; 34(4):425-433. PubMed ID: 30251947
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A
Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163
[TBL] [Abstract][Full Text] [Related]
14. Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment.
Feldman SR; Thyssen JP; Boeri M; Gerber R; Neary MP; Cha A; Hauber B; Cappelleri JC; Xenakis J; Leach C; Zeichner J
J Dermatolog Treat; 2024 Dec; 35(1):2304020. PubMed ID: 38221777
[No Abstract] [Full Text] [Related]
15. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
[TBL] [Abstract][Full Text] [Related]
16. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
[TBL] [Abstract][Full Text] [Related]
17. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
Sicsic J; Pelletier-Fleury N; Moumjid N
Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
[TBL] [Abstract][Full Text] [Related]
18. Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice Experiment.
Livingstone A; Howard K; Menzies AM; Long GV; Stockler MR; Morton RL
Patient; 2023 Sep; 16(5):497-513. PubMed ID: 37351797
[TBL] [Abstract][Full Text] [Related]
19. Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania.
Simons G; Veldwijk J; DiSantostefano RL; Englbrecht M; Radawski C; Bywall KS; Valor Méndez L; Hauber B; Raza K; Falahee M
Rheumatology (Oxford); 2023 Feb; 62(2):596-605. PubMed ID: 36068022
[TBL] [Abstract][Full Text] [Related]
20. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
